Online citations, reference lists, and bibliographies.

Comparative Interaction Of Cimetidine And Ranitidine With Racemic Warfarin In Man.

R. O'Reilly
Published 1984 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Cimetidine potentiates the anticoagulant effect of warfarin sodium, but in one small study ranitidine hydrochloride did not. Furthermore, these drugs have not been compared in the same subjects. Eleven normal subjects received single oral doses of 1.5 mg/kg racemic warfarin sodium alone, with cimetidine (1,200 mg/day orally), or with ranitidine (300 mg/day orally), beginning three days before the warfarin and daily thereafter for the duration of hypoprothrombinemia. Blood samples were obtained daily for determination of prothrombin times and warfarin concentrations. Cimetidine augmented both the hypoprothrombinemia and the blood concentrations of warfarin, but ranitidine did not. Substituted imidazoles like cimetidine inhibit hepatic microsomal activity, which may cause reduced metabolic clearance of warfarin and augment its anticoagulant effect. Ranitidine, lacking these effects, may be safer for patients undergoing anticoagulation who require H2-receptor antagonists.



This paper is referenced by
10.1111/J.1523-1755.2005.00182.X
Impact of gastric acid suppressants on cytochrome P450 3A4 and P-glycoprotein: consequences for FK506 assimilation.
W. Lemahieu (2005)
10.1016/B978-044482406-6/50008-3
CHAPTER 2 – Drug Interactions with Agents Used in the Treatment of Cardiovascular Disease
J. Griffin (1997)
10.1159/000076934
Variability in Cytochrome P450-Mediated Metabolism of Cardiovascular Drugs: Clinical Implications and Practical Attempts to Avoid Potential Problems
E. Molden (2004)
10.1038/clpt.1987.104
Enoxacin‐warfarin interaction: Pharmacokinetic and stereochemical aspects
S. Toon (1987)
10.1007/978-1-4757-1520-0
Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development
C. Peck (1993)
10.3904/kjim.2014.29.4.498
Evaluation of risk factors in patients with vitamin K-dependent coagulopathy presumed to be caused by exposure to brodifacoum
Hee-Jeong Lee (2014)
10.1002/j.1552-4604.1990.tb03634.x
Norfloxacin Does Not Alter Warfarin's Disposition or Anticoagulant Effect
Mario L. Rocci (1990)
10.1177/106002808602000502
The Hepatic and Renal Mechanisms of Drug Interactions with Cimetidine
M. Nazario (1986)
10.1177/106002808501901217
Ranitidine Does Not Alter Single-Dose Carbamazepin Pharmacokinetics in Healthy Adults
M. Dalton (1985)
10.1177/106002809402800923
Fluvastatin Cost Considerations
W. Garnett (1994)
10.1016/S0749-0690(05)70102-6
Oral anticoagulants. Pharmacologic issues for use in the elderly.
E. Hylek (2001)
10.1007/BF03190016
Effect of tacrine hydrochloride on hepatic drug metabolism
T. Danbury (2010)
10.1001/ARCHINTE.165.10.1095
Systematic overview of warfarin and its drug and food interactions.
A. Holbrook (2005)
10.1007/s40262-019-00844-3
A Systematic Review of Gastric Acid-Reducing Agent-Mediated Drug–Drug Interactions with Orally Administered Medications
Divya Patel (2019)
10.1177/1060028089023S1003
Comparison of the Parenteral Histamine2-Receptor Antagonists
V. A. Skoutakis (1989)
10.1177/106002808501900909
Drug Information Analysis Service
L. Hart (1985)
10.1002/j.1552-4604.1988.tb05727.x
Lack of Interaction Between Nizatidine and Warfarin During Chronic Administration
A. Cournot (1988)
10.7326/0003-4819-121-9-199411010-00009
Interactions of Warfarin with Drugs and Food
P. Wells (1994)
The pharmacokinetics and pharmacodynamics of single dose ( R )-and ( S )-warfarin administered separately and together : relationship to VKORC 1 genotype
J. C. Maddison (2012)
10.1177/106002809402800922
Fluconazole—Warfarin Interaction
A. M. Baciewicz (1994)
10.1177/106002808902300911
Do All Histamine2-Antagonists Cause a Warfarin Drug Interaction?
D. Thompson (1989)
10.1177/106002809402800920
Dyspnea and Periorbital Edema following an Increase in Naproxen Dose
L. Briscoe-Dwyer (1994)
10.1007/BF00542424
Lack of effect of cimetidine on pharmacodynamics and kinetics of single oral doses of R- and S-acenocoumarol
H. Thijssen (1986)
10.1007/BF00542190
Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man
S. Toon (1987)
10.1002/j.1552-4604.1995.tb04018.x
Losartan Does Not Affect the Pharmacokinetics and Pharmacodynamics of Warfarin
A. Kong (1995)
10.1177/106002808301701201
Ranitidine Hydrochloride
T. Gaginella (1983)
10.3109/00498250701620700
Comparison of different approaches to predict metabolic drug–drug interactions
H. Einolf (2007)
10.1007/s002280050647
The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans
I. Niopas (1999)
10.1111/j.1365-2710.2007.00891.x
Prevalence and predictors of potential drug–drug interactions in Regione Emilia‐Romagna, Italy
J. Gagne (2008)
10.1124/dmd.112.045799
In Vivo Information-Guided Prediction Approach for Assessing the Risks of Drug-Drug Interactions Associated with Circulating Inhibitory Metabolites
Zhe-yi Hu (2012)
10.1002/BDD.2510160903
The effect of three H2 receptor antagonists on the disposition of cyclosporin a in the in situ perfused rat liver model
C. Hughes (1995)
10.1046/j.1365-2036.1997.136312000.x
The safety of ranitidine in over a decade of use
J. G. Mills (1997)
See more
Semantic Scholar Logo Some data provided by SemanticScholar